Original Articles (2016-2020)

  1. Ozawa S, Matsubayashi M, Nanaura H, Yanagita M, Mori K, Asanuma K, Kajiwara N, Hayashi H, Ohashi H, Kasahara M, Yokoi H, Kataoka H, Mori E, Nakagawa T. Proteolytic cleavage of podocin by matriptase exacerbates podocyte injury. J. Biol. Chem., 295:16002-16012 (2020)
  2. Miike T, Kawakami H, Kameda T, Yamamoto S, Tahara Y, Hidaka T, Kubuki Y, Yorita K, Akiyama Y, Arimura Y, Kubota Y, Kataoka H, Shimoda K. Clinical characteristics of adult T-cell leukemia/lymphoma infiltration in the gastrointestinal tract. BMC Gastroenterol., 20(1):298 (2020)
  3. Hamada T, Ishizaki H, Haruyama Y, Hamada R, Yano K, Kondo K, Kataoka H, Nanashima A. Neutrophil-to-lymphocyte ratio and intratumoral CD45RO-positive T cells as predictive factors for longer survival of patients with colorectal liver metastasis after hepatectomy. Tohoku J. Exp. Med., 251: 303-311 (2020)
  4. Kawaguchi M, Yamamoto K, Kataoka H, Izumi A, Yamashita F, Kiwaki T, Nishida T, Camerer E, Fukushima T. Protease-activated receptor-2 accelerates intestinal tumor formation through activation of nuclear factor-κB signaling and tumor angiogenesis in ApcMIN/+ mice. Cancer Sci., 111(4):1193-1202 (2020)
  5. Akizuki K, Sekine M, Kogure Y, Kameda T, Shide K, Koya J, Kamiunten A, Kubuki Y, Tahira Y, Hidaka T, Kiwaki T, Tanaka H, Sato Y, Kataoka H, Kataoka K, Shimoda K. TP53 and PTEN mutations were shared in concurrent germ cell tumor and acute megakaryoblastic leukemia. BMC Cancer, 20(1):5 (2020)
  6. Liu HS, Ishizuka T, Kawaguchi M, Nishii R, Kataoka H, Xu Y. A Nucleoside Derivative 5-Vinyluridine (VrU) for Imaging RNA in Cells and Animals Bioconjug Chem., 30(11):2958-2966 (2019)
  7. Yorita K, Ohno A, Nishida T, Kondo K, Ohtomo T, Kataoka H. Intratumoral reciprocal expression of monocarboxylate transporter 4 and glypican-3 in hepatocellular carcinomas. BMC Research Notes , 12:741 (2019)
  8. Kawaguchi M, Yamamoto K, Takeda N, Fukushima T, Yamashita F, Sato K, Kitamura K, Hippo Y, Janetka JW, Kataoka H. Hepatocyte growth factor activator inhibitor-2 stabilizes Epcam and maintains epithelial organization in the mouse intestine. Communications Biology, 2: 11 (2019)
  9. 小牧亘, 深野木快士,濱田浩朗, 帖佐悦男, 田中弘之，片岡寛章: 病理所見より検討した非定型大腿骨骨折の骨癒合遷延の要因. 骨折, 41: 267-272 (2019)
  10. Yamasaki K, Mukai S, Nagai T, Nakahara K, Fujii M, Terada N, Ohno A, Sato Y, Toda Y, Kataoka H, Kamoto T. Matriptase-induced phosphorylation of MET is significantly associated with poor prognosis in invasive bladder cancer; an Immunohistochemical Analysis. Int. J. Mol. Sci.,19: 3708 (2018)
  11. 武安智樹, 有村保次, 米澤ゆう子、深尾　悠、舩元太郎、古市佳代、上野浩晶、松元信弘、江藤　望、片岡寛章. ：BCAA含有飲料「百白糀」摂取に伴う急性期筋肉疲労軽減効果の検討―ランダム化オープン・プラセボ対照クロスオーバー試験. 薬理と治療 , 46: 1177 - 1190 (2018)
  12. 小牧亘, 深野木快士, 舩元太郎, 濱田浩朗, 帖佐悦男, 田中弘之, 馬場貴 ：当院における４例の非定型大腿骨骨折の組織学的所見の検討. 日本骨粗鬆症学会雑誌 , 4:47 (2018)
  13. Fukushima T, Kawaguchi M, Yamamoto K, Yamashita F, Izumi A, Kaieda T, Takezaki Y, Itoh H, Takeshima H, Kataoka H. Aberrant methylation and silencing of the SPINT2 gene in high-grade gliomas. Cancer Sci., 109: 2970-2979 (2018)
  14. Yamasaki K, Mukai S, Sugie S, Nagai T, Nakahara K, Kamibeppu T, Terada N, Sakamoto H, Shibazaki N, Toda Y, Kataoka H, Kamoto T. Dysregulated HAI-2 plays an important role in renal cell carcinoma bone metastasis through ligand-dependent MET phosphorylation. Cancers, 10:190 (2018)
  15. Lee D, Taniguchi N, Sato K, Choijookhuu N, Hishikawa Y, Kataoka H, Morinaga H, Lotz M, Chosa E. HMGB2 is a novel adipogenic factor that regulates ectopic fat infiltration in skeletal muscles. Sci. Rep., 8:9601 (2018)
  16. Yamamoto K, Kawaguchi M, Shimomura T, Izumi A, Konari K, Honda A, Lin CY, Johnson MD, Yamashita Y, FukushimaT and Kataoka K. Hepatocyte growth factor activator inhibitor type-2 (HAI-2)/SPINT2 contributes to invasive growth of oral squamous cell carcinoma cells. Oncotarget, 9:11691-11706 (2018)
  17. Moritake H, Obara M, Saito Y, Kashimada A, Takagi M, Funakoshi-Tago M, Fukuyama T, Yoshioka M, Inoue A, Komatsu H, Nishitoh H, Kataoka H, Nunoi H. A mouse model reveals that Mfsd2a is critical for unfolded protein response upon exposure to tunicamycin. Hum. Cell, 30: 88-97 (2017)
  18. Sakugawa C, Haruyama Y, Tanaka H,Fukushima T, Kawaguchi M, Kataoka H. Prognostic significance of hepatocyte growth factor activator inhibitor type 1(HAI-1)immunoreactivity in pancreatic ductal adenocarcinoma. BMC Research Notes, 10:674 (2017)
  19. Nonboe AW, Krigslund O, Soendergaard C, Skovbjerg S, Friis S, Andersen MN, Ellis V, Kawaguchi M, Kataoka H, Bugge TH, Vogel LK. HAI-2 stabilizes, inhibits, and regulates SEA-cleavage-dependent secretory transport of matriptase. Traffic, 18 : 378-391 (2017)
  20. Kanemaru A, Yamamoto K, Kawaguchi M, Fukushima T, Lin CY, Johnson MD, Camerer E, Kataoka H. Deregulated matriptase activity in oral squamous cell carcinoma promotes the infiltration of cancer‐associated fibroblasts by paracrine activation of protease‐activated receptor 2. Int. J. Cancer, 140:130-141 (2017)
  21. Kawaguchi M, Yamamoto K, Kanemaru A, Tanaka H, Umezawa K, Fukushima T, Kataoka H. Inhibition of nuclear factor-κB signaling suppresses Spint1-deletion-induced tumor susceptibility in the ApcMin/+ model. Oncotarget, 7:68614-68622 (2016)
  22. Inagaki-Ohara K, Okamoto S, Takagi K, Saito K, Arita S, Tang L, Hori T, Kataoka H, Matsumoto S, Minokoshi Y. Leptin receptor signaling is required for high-fat diet-induced atrophic gastritis in mice. Nutrition & Metabolism, 13:7 (2016)